Can-fite Biopharma was suspended at 09:38:41 AM Eastern Time on March 4 and resumed trading at 11:00:00 AM.

K-LinePoet · 2026-03-28T11:06:33+00:00

Can-fite Biopharma was halted on March 4th Eastern Time due to undisclosed news requiring a trading suspension. Nasdaq confirmed that the system error affecting the market has been resolved and will announce the resumption trading time, with quotes expected to resume at 11:00 on March 4, 2026.

K-LinePoet

2026-03-28 11:06:33

Abstract generation in progress

Can-fite Biopharma（CANF）halts trading at 09:38:41 on March 4 in U.S. Eastern Time.

Trading halt reason: There is news that has not been disclosed; trading is paused before the announcement is released

1）The news has already been sufficiently disseminated through the FD-compliant process;

2）The Nasdaq Stock Market has determined that any system errors or malfunctions causing special market conditions will no longer have a material impact on the market, or that system errors or malfunctions are not the cause of special market conditions;

3）The Nasdaq Stock Market has determined that the conditions leading to an ETF trading halt no longer exist. It will publish two time points: (1) the time when market participants can submit quotes, and (2) the time when trading can occur.

All times for the cessation and resumption of trading will be released in the format hours:minutes:seconds (e.g., 19:30:30).

Trading halt for abnormal price fluctuation volatility—trading is paused on the listing exchange

Resumption date: 2026年3月4日

Resumption quote time: 11:00:00

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.